Read prostate MRI at expert level supported by AI

Request a demo

Quantib^® Prostate is here to help you manage the increase in prostate MRI workload and streamline the radiology workflow.

The FDA cleared zero-footprint artificial intelligence-based software provides a workflow for the detection of abnormalities on MRI prostate scans.

Yearly, 1.3M men are diagnosed with prostate cancer, often without the use of MRI, while NEJM and The Lancet report strong benefits of MRI.^1,2

New guidelines adopted by EAU and ACR advise to include MRI prior to all 3M biopsies taken yearly in Europe and the United States.^3,4

Radiology practices already see a doubling in case load of multiparametric MRI prostate scans.

¹Taneja, S. S. et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N. Engl. J. Med. 378, 1767–1777 (2018).
²Ahmed, H. U. et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389, 815–822.
³Andrew B. Rosenkrantz, M. et al. ACR - Prostate MRI Model Policy. Available at: https://www.acr.org/-/media/ACR/Files/Advocacy/AIA/Prostate-MRI-Model-Policy72219.pdf. (Accessed: 7th May 2020)
⁴Mottet, N. et al. European Association of Urology - Prostate Cancer. 2020 Available at: https://uroweb.org/guideline/prostate-cancer/. (Accessed: 7th May 2020)

The current prostate MRI reading workflow is lengthy, labour-intensive and requires substantial practice to master.

What if you could have...

One solution,
one workflow

No more switching between PACS, PSA density calculation feature and PI-RADS support; Quantib^® Prostate offers one workflow including all essential prostate MRI reading features.

AI-based support for
lesion assessment

Semi-automated combination of bi-parametric data supports ROI determination and enables prostate lesion evaluation. AI-bolstered segmentation allows for easy and fast determination of lesion volume.

Click-of-a-button
reporting

After prostate MRI assessment, a customized report is created including PSA density, quantified volumes, PI-RADS v.2.1 scoring and key images of suspicious regions.

Product overview

Key features include

AI-driven prostate volume measurements
Integrated PSA density calculation
Fast, AI-supported ROI segmentation of suspicious areas
Visual PI-RADS v.2.1 scoring support
Export of prostate gland segmentation, ROIs and standardized report to PACS
A structured report including key images and visual representation of PI-RADS v.2.1 results

Learn More

prostate radiology software Quantib Prostate user interface on desktop monitor showing PIRADS scoring

Quantib^® Prostate is currently 510(k) cleared by the FDA for distribution in the US. This product has not been proven to conform to all requirements of the European Medical Device Regulations (2017/745). Not commercially available in the EU and other countries.

Curious to learn more about Quantib^® Prostate?

Request a demo

Learn from our resources

ULTIMATE GUIDE

The Ultimate Guide to AI in Prostate Cancer

How does artificial intelligence work? What are promising AI applications in the prostate cancer pathway? Which solutions are available now?

How AI can help with Quantification in Radiology

The benefits of AI for radiology are numerous. Tim Leiner, Professor of Radiology at the Department of Radiology, Utrecht University Medical Center in Utrecht, The Netherlands discusses how AI-powered tools can support the radiologists in their daily clinical workflow

WATCH VIDEO